Medigen Biotechnology Corp.
Records under this name other than the patents Medigen Biotechnology Corp. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 3 of 3 · Back to Medigen Biotechnology Corp.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,890,206 | H1N1 flu virus neutralizing antibodies Lapsed on the fee record Ended Feb 13, 2026 · USPTO record | Lapsed on the fee record | Ended Feb 13, 2026 | USPTO record |
| US 7,507,532 | Cancer specific gene MH15 Lapsed on the fee record Ended Mar 24, 2017 · USPTO record | Lapsed on the fee record | Ended Mar 24, 2017 | USPTO record |
| US 7,387,806 | Method of using geranium oil and sophora root extracts as a supporting composition in cancer treatments Lapsed on the fee record Ended Jun 17, 2016 · USPTO record | Lapsed on the fee record | Ended Jun 17, 2016 | USPTO record |